| Literature DB >> 34942972 |
Aneta Wojdyło1, Paulina Nowicka1.
Abstract
In view of the limited information available in the literature concerning leaves as by-products of Prunus armeniaca cultivation, the aim of this work was to identify and characterize their principal polyphenolic constituents by LC-ESI-QTOF-MS/MS and screening in vitro biological potency as antioxidant capacity (ABTS, online ABTS, FRAP, ORAC), antidiabetic (α-amylase, α-glucosidase), anti-obesity (pancreatic lipase), anti-cholinesterase (AChE and BChE), and anti-inflammatory (COX-1 and COX-2) inhibitory activity. Comparison of different polyphenolic extracts of P. armeniaca cultivar leaves according to their quantitative composition revealed them to be exceptional sources of hydroxycinnamic acids, and to a lesser extent as sources of flavonols. Polyphenol-rich apricot leaf extract (PrALe) showed the most effective anti-obesity action through inhibition of pancreatic lipase, COX-1 and antioxidant capacity, especially the oxygen radical absorbance capacity, which was particularly correlated with polyphenolic compounds. Online ABTS radical UPLC-PDA-PDA analysis clearly demonstrated that the three predominant compounds of PrALe are quercetin-3-O-rutinoside > 5-O- and 3-O-caffeoylquinic acid, which basically contribute to antioxidant potential. These results assist in the evaluation of plant sources of potential new raw materials for application in different commercial sectors, especially for food, cosmetics and pharmaceuticals production.Entities:
Keywords: BChE; COX; FRAP; ORAC; online ABTS; pancreatic lipase AChE; α-amylase; α-glucosidase
Year: 2021 PMID: 34942972 PMCID: PMC8698879 DOI: 10.3390/antiox10121869
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Retention time (Rt), wavelengths (λmax) of maximum absorption in the visible region, mass spectral data, identification, and quantification (mean ± SD) of phenolic compounds of the PrALe by LC-ESI-QTOF-MS/MS.
| Tentative Identification | Molecular Formula | Rt (min) | λmax (nm) | Molecular Ion [M-H] ( | Main MS/MS Fragments | Quantification [mg/kg] | ||
|---|---|---|---|---|---|---|---|---|
| Somo | Harcot | Early Orange | ||||||
| Hydroxycinnamic acids | ||||||||
| 3- | C16H18O9 | 5.87 | 324 | 353.22 | 191.23 | 24.27 ± 0.90 b | 46.89 ± 1.43 a | 22.42 ± 1.11 b |
| Caffeoyl-glucoside | C15H18O9 | 6.15 | 331 | 341.22 | 179.01/162.20/135.22 | 4.50 ± 0.32 c | 8.42 ± 0.45 b | 13.13 ± 0.12 a |
| 4-O-caffeoylquinic acid | C16H18O9 | 6.25 | 331 | 353.22 | 191.23/161.20 | 4.82 ± 0.42 c | 9.49 ± 0.52 b | 15.19 ± 0.32 a |
| 3- | C16H18O8 | 7.00 | 311 | 337.23 | 163.22 | 6.65 ± 0.11 bc | 7.75 ± 0.73 b | 15.92 ± 0.43 a |
| 5- | C16H18O9 | 7.50 | 325 | 353.22 | 191.23/179.21/135.22 | 152.71 ± 2.54 c | 216.39 ± 2.13 b | 316.98 ± 2.49 a |
| C15H17O8 | 7.90 | 311 | 325.23 | 163.22 | 11.15 ± 0.67 a | 1.26 ± 0.10 c | 3.39 ± 0.32 b | |
| 3- | C17H20O9 | 7.97 | 325 | 367.23 | 193.21/173.22 | 3.74 ± 0.12 b | 12.12 ± 0.52 a | 0.93 ± 0.09 c |
| Feruloyl-glucoside | C16H20O9 | 8.64 | 328 | 355.23 | 193.12/175.21/162.20 | 7.31 ± 0.23 c | 9.02 ± 0.23 b | 11.19 ± 0.21 a |
| C16H18O9 | 9.10 | 314 | 353.22 | 191.23/161.20 | 5.69 ± 0.56 b | 7.00 ± 0.56 a | 2.60 ± 0.22 c | |
| 5- | C16H18O8 | 9.19 | 315 | 337.23 | 191.23/173.22/163.22 | 2.60 ± 0.22 bc | 8.02 ± 0.89 a | 3.07 ± 0.16 b |
| 4- | C17H20O9 | 11.10 | 316 | 367.23 | 193.21/191.23/173.22 | nd | 1.22 ± 0.11 a | 1.28 ± 0.19 a |
| Flavonols | ||||||||
| Quercetin-3- | C27H30O16 | 11.60 | 264/355 | 609.14 | 301.18 | nd | 13.31 ± 0.56 a | nd |
| Quercetin-3- | C27H30O16 | 11.77 | 258/354 | 609.14 | 301.18 | 222.11 ± 2.65 a | 198.22 ± 1.89 b | 35.19 ± 0.51 c |
| Quercetin-3- | C21H20O12 | 12.25 | 261/354 | 463.17 | 301.18 | 3.41 ± 0.34 b | 4.79 ± 0.13 a | 3.35 ± 0.23 b |
| Kaempferol-3- | C27H30O11 | 13.03 | 265/341 | 593.16 | 308.11/285.19 | 9.85 ± 0.67 b | 21.70 ± 0.99 a | 2.79 ± 0.11 c |
| Polymeric procyanidin | 33.38 ± 1.23 c | 83.54 ± 1.54 a | 60.83 ± 1.43 b | |||||
| Degree of polymerisation | 2.01 | 2.63 | 2.83 | |||||
| Tota polyphenols [g/kg] | 492.20 BC | 649.13 A | 508.27 B | |||||
nd—not detected; data are shown as mean (n = 3) ± standard deviation; a–c or A–C—in each row, different letters indicates the significant differences at p < 0.05 between samples (Tukey’s HSD test).
Antioxidant capacity (ORAC, FRAP, ABTS; mmol TE/100 g dw), enzymatic in vitro enzyme inhibition of hyperglycemic (α-glucosidase, α-amylase; IC50, mg/mL), obesity (pancreatic lipase; IC50, mg/mL), cholinesterase (acetylcholinesterase, butylcholinesterase; %), and inflammatory (COX-1 and -2; IC50, mg/mL) of PrALe.
| Analysis | Polyphenol-Rich Apricot Leaf Extract | ||
|---|---|---|---|
| Somo | Harcot | Early Orange | |
| ABTS | 167.83 ± 1.98 a | 72.75 ± 2.54 c | 131.47 ± 1.45 b |
| FRAP | 71.43 ± 1.00 a | 50.41 ± 1.89 b | 17.13 ± 1.01 c |
| ORAC | 411.85 ± 2.67 a | 297.51 ± 3.76 b | 312.57 ± 3.54 b |
| AChE | 5.53 ± 0.41 b | 10.33 ± 1.55 a | 9.68 ± 1.22 a |
| BChE | 5.93 ± 0.11 bc | 6.87 ± 0.25 b | 8.55 ± 0.43 a |
| α-Amylase | 3.32 ± 0.05 a | 7.52 ± 0.32 b | 7.23 ± 0.21 b |
| α-Glucosidase | 3.35 ± 0.6 c | 1.30 ± 0.11 b | 0.71 ± 0.05 a |
| Pancreatic lipase | 0.17 ± 0.01 a | 0.21 ± 0.03 a | 0.16 ± 0.01 a |
| COX 1 | 2.19 ± 0.21 b | 0.74 ± 0.06 a | 0.94 ± 0.04 a |
| COX 2 | 1.81 ± 0.16 a | 2.22 ± 0.03 ab | 9.69 ± 0.10 c |
ABTS-2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) radical cation; FRAP-the Ferric Reducing Ability of Plasma; ORAC-the Oxygen Radical Absorbance Capacity; AChE-acetylcholinesterase; BChE-butylcholinesterase; COX-cyclooxygenase; Data are shown as mean (n = 3) ± standard deviation; a–c—in each row, different letters mean significant differences between samples ((Tukey’s HSD test, p < 0.05); IC50 values correspond to the extract concentration achieving 50% of activity. Data are shown as mean (n = 3) ± standard deviation; a–c—in each row, different letters indicate the significant differences at p < 0.05 between samples (Tukey’s test).
Figure 1HPLC-PDA traces at 280 nm and on-line antioxidant detection (734 nm) basic polyphenols component of PrALe of Harcot cv. HA2-4-O-caffeoylquinic acid; HA3-3-p-coumaroyl-quinic acid; HA4-5-O-caffeoylquinic acid; HA5-p-coumaroyl-glucoside; HA8-cis-5-O-caffeoylquinic acid; HA10-4-O-feruloylquinic acid; Q1-quercetin-3-O-rutionoside; Q2-quercetin-3-O-rutinoside; Q3-quercetin-3-O-galactoside; Q4-keampferol-3-O-rutinoside; PP-polymeric procyanidins.
Figure 2Biplot (PC1 × PC2) of scores and loadings for the PrALe, antioxidant capacity, and enzyme inhibitory. HA1-caffeoyl-glucoside; HA2-4-O-caffeoylquinic acid; HA3-3-p-coumaroyl-quinic acid; HA4-5-O-caffeoylquinic acid; HA5-p-coumaroyl-glucoside; HA6-3-O-feruloylquinic acid; HA7-feruloyl-glucoside; HA8-cis-5-O-caffeoylquinic acid; HA9-5-p-coumaroylo-quinic acid; HA10-4-O-feruloylquinic acid; Q1-quercetin-3-O-rutionoside; Q2-quercetin-3-O-rutinoside; Q3-quercetin-3-O-galactoside; Q4-keampferol-3-O-rutinoside; PP-polymeric procyanidins; ORAC-the Oxygen Radical Absorbance Capacity; AChE-acetylcholinesterase; BChE-butylcholinesterase; COX-cyclooxygenase.